Download PDF

Other users also viewed these articles

Clinical effectiveness and safety of vedolizumab versus infliximab in biologic-naïve patients with ulcerative colitis: A comparative real-world multicentric observational study Sandro da Costa Ferreira; Rogério Serafim Parra; Ligia Yukie Sassaki; José Miguel Luz Parente; Munique Kurtz de Mello; Liliana Andrade Chebli; Rafael Luís Luporini; Antonio José Tiburcio Alves Junior; Fernando Jorge Firmino Nóbrega; Bruno César da Silva; Eron Fábio Miranda; Abel Botelho Quaresma; Guilherme Mattioli Nicollelli; Rodrigo Galhardi Gasparini; Renata de Medeiros Dutra; Juarez Roberto de Oliveira Vasconcelos; Katia da Conceição da Silva; Daniéla Oliveira Magro; Marcello Rabello Imbrizi; Cristiane Kibune Nagasako; Omar Féres; Luiz Ernesto de Almeida Troncon; Paulo Gustavo Kotze; Júlio Maria Fonseca Chebli;
Gastroenterol Hepatol. 2025;48:
The impact of anxiety and depression on quality of life in a cohort of inflammatory bowel disease patients from Northeastern of Brazil Raiza Lima Silva; Francisca Isabelle da Silva e Sousa; Gabriel Lucas Ferreira da Silva; Victória Danielly Rabelo Almeida; Simão Barbosa Silva; Mateus Mendes Santos Freire; Marcellus Henrique Loiola Ponte de Souza; Lucia Libanez Bessa Campelo Braga;
Gastroenterol Hepatol. 2025;48:
Position statement of the Spanish Working Group on Crohn¿s Disease and Ulcerative Colitis on the use of Telemedicine in Inflammatory Bowel Disease Mariam Aguas Peris; Javier del Hoyo Francisco; Pilar Nos Mateu; Ana Echarri Piudo; Marta Calvo Moya; Beatriz Gros; María Dolores Martín-Arranz; Emilio Monte Boquet; Sergio Inglán Agustín; Antonio Valdivia Martínez; Marisa Correcher; Manuel Barreiro-de Acosta; Miriam Mañosa Ciria; Francisco Rodriguez-Moranta; Yamile Zabana; Ana Gutiérrez Casbas;
Gastroenterol Hepatol. 2025;48: